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AbstrACt
Objectives To assess to what extent triage criteria, client 
and regional characteristics explain regional differences 
in Chlamydia trachomatis (Ct) and Neisseria gonorrhoeae 
(Ng) positivity in sexually transmitted infection (STI) 
clinics.
Design Retrospective cross-sectional study on the Dutch 
STI surveillance database of all 24 STI clinics.
Participants STI clinic visits of heterosexual persons in 
2015 with a Ct (n=101 495) and/or Ng test (n=101 081).
Primary outcome measure Ct and Ng positivity and 
95% CI was assessed for each STI clinic. Two-level logistic 
regression analyses were performed to calculate the 
percentage change in regional variance (PCV) after adding 
triage criteria (model 1), other client characteristics (model 
2) and regional characteristics (model 3) to the empty 
model. The contribution of single characteristics was 
determined after removing them from model 3.
results Ct positivity was 14.9% and ranged from 12.6% 
to 20.0% regionally. Ng positivity was 1.7% and ranged 
from 0.8% to 3.8% regionally. For Ct, the PCV was 11.7% 
in model 1, 32.2% in model 2% and 59.3% in model 
3. Age, notified for Ct (triage), level of education (other 
characteristics) and regional degree of urbanisation 
(region) explained variance most. For Ng, the PCV was 
38.7% in model 1, 61.2% in model 2% and 69.1% in 
model 3. Ethnicity (triage), partner in risk group, level of 
education and neighbourhood (other characteristics) and 
regional socioeconomic status (SES) explained variance 
most. A significant part of regional variance remained 
unexplained.
Conclusions Regional variance was explained by 
differences in client characteristics, indicating that 
triage and self-selection influence positivity rates in 
the surveillance data. Clustering of Ng in low SES 
regions additionally explained regional variance in Ng; 
targeted interventions in low SES regions may assist Ng 
control. Including educational level as triage criterion is 
recommended. Studies incorporating prevalence data are 
needed to assess whether regional clustering underlies 
unexplained regional variance.
IntrODuCtIOn 
Chlamydia trachomatis (Ct) and Neisseria gonor-
rhoeae (Ng) are the most common bacterial 
sexually transmitted infections (STI) among 
heterosexual men and women in Europe.1 
In the Netherlands, Ct and Ng diagnostic 
tests are mainly performed by general practi-
tioners (GP) and STI clinics at Public Health 
Services, resulting in an estimated total 
number of 400 000 STI consultations nation-
wide. In 2016, it was estimated that approxi-
mately 20 000 Ct infections were diagnosed 
at the STI clinics and 35 000 at the GP. For Ng 
infections these number are 6000 and 8000, 
respectively.2 The GP is accessible to everyone 
in society and offers Ct and Ng testing on 
request. Laboratory tests at the GP are reim-
bursed by the insurance. However, a drawback 
strengths and limitations of this study
 ► The large nationwide database covering all sexu-
ally transmitted infection (STI) clinic consultations 
of heterosexuals with a large set of demograph-
ic and behavioural characteristics enabled us to 
study a range of explanatory variables for regional 
Chlamydia trachomatis and Neisseria gonorrhoeae 
positivity differences.
 ► By using a multilevel approach, it was possible to 
quantify the contribution of characteristics of STI 
clinic visitors to the regional variance in positivity.
 ► Some consultation data were incomplete for some 
variables of interest (15%), which limited the gener-
alisability of our results, although a separate analy-
sis did not show distortion of our results.
 ► As we studied only STI clinic visitors and did not in-
clude patients from general practitioners, our results 
are not generalisable to all patients with STI.
 o
n
 28 February 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022793 on 21 January 2019. Downloaded from 
2 Götz HM, et al. BMJ Open 2019;9:e022793. doi:10.1136/bmjopen-2018-022793
Open access 
is that the first few hundred Euros of healthcare costs are 
not deductible, and consequently STI tests are not always 
reimbursed. Public health-oriented STI clinics have been 
introduced nationwide in 2006 to provide confidential 
and free-of-charge STI testing and treatment for high-risk 
groups. Men who have sex with men (MSM) are eligible 
for regular testing at STI clinics and MSM consultations 
are disproportionally high at STI clinics. Heterosexuals 
are eligible to the STI clinic testing and treatment when 
they fulfil at least one of the high-risk triage criteria: noti-
fied by a partner for STI, STI-related symptoms, aged 
below 25 years, having a high risk for STI (eg, originating 
from or having a partner from an STI-endemic country 
or working as a commercial sex worker (CSW)) and/
or victims of sexual violence. All STI clinic visitors are 
routinely tested for chlamydia and gonorrhoeae, syphilis, 
HIV (with the possibility to opt-out) and hepatitis B/C 
(on indication). Previously, all visitors to the STI clinics 
got fully tested for Ct and Ng and for HIV and syphilis, 
but since 2015, those younger than 25 years are all tested 
for Ct and Ng and on indication for HIV and syphilis.3 
Despite national triage criteria and test policy, there are 
regional differences in the number of consultations and 
in Ct and Ng positivity among heterosexual STI clinic 
visitors. Explanations might be found in variations in 
the proportion of certain high-risk characteristics of STI 
clinic visitors and in variations in regional characteristics 
related to positivity. Knowledge about these underlying 
factors might improve our understanding of the surveil-
lance data and may possibly inform priority setting for STI 
clinics. In this study, we assess regional differences in Ct 
and Ng positivity among heterosexual STI clinic visitors 
between the 24 Dutch public health STI clinic regions. 
Our main objective is to identify explanatory factors of 
regional variance in Ct and Ng positivity, especially client 
and regional characteristics.
MethODs
Data collection
Data on STI clinic consultations and diagnoses in 2015 
were obtained from the Dutch national STI surveillance 
database (SOAP), in which a predefined set of char-
acteristics (including STI risk factors, diagnostic tests 
performed and outcomes measured) of all consultations 
at the 24 Dutch Public Health STI clinics is mandatory 
and routinely collected on a pseudonymous basis (unique 
numerical identifier per person which is not traceable to 
a person).4 The 24 STI clinics are scattered throughout 
the country (figure 1). In the SOAP database, all consul-
tations of heterosexual STI clinic visitors in 2015 were 
selected (n=101 710). This database was merged with 
demographic data for each clients’ four-digit zip code 
(degree of urbanisation, socioeconomic status (SES) on 
neighbourhood level) and for each of the 24 STI clinic 
regions (distribution of age, gender, non-Western origin, 
degree of urbanisation, SES). Demographic data on age, 
gender, origin and degree of urbanisation in 2015 were 
obtained from ‘Statline’ ( statline. cbs. nl), an open-access 
platform providing freely downloadable data of Statistics 
Netherlands (CBS). Demographic data on SES in 2014 
was requested at the Netherlands Institute for Social 
Research (SCP). In this merged dataset, only consulta-
tions with a Ct test were selected for Ct analyses (n=101 
495) and only consultations with an Ng test were selected 
for Ng analyses (n=101 081). For an overview of all vari-
ables see table 1.
The data were routinely and pseudonymously collected 
for surveillance purposes and therefore the study was 
exempt from formal medical ethical approval under 
prevailing laws in the Netherlands.
explanatory variables
Triage criteria
All triage criteria were included in the analyses: age, 
being notified by a sex partner for chlamydia (in Ct anal-
yses), notified for gonorrhoea (in Ng analyses), STI-re-
lated symptoms, CSW, originating from an STI-endemic 
country, partner from risk group and Ct/Ng/syphilis 
infection in the previous year.3
The continuous variable age was categorised 
in age groups because of the non-linear relation 
between age and the log odds of the outcomes chla-
mydia and gonorrhoea. The categories were based 
on the relation between age and the outcomes on a 
log odds scale. We chose <20, 20–24, 25–29, 30–34, 
≥35 for Ct analyses and <20, 20–24, 25–39, ≥40 
years for Ng analyses. The presence of STI-related 
symptoms was unknown in 0.6% of consultations. 
Figure 1 Sexually transmitted infection clinics in public 
health service regions. Blue dot is location clinic.
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We assumed that these persons did not have symp-
toms and were therefore included in the category 
‘no symptoms’. Migratory background was based 
on the definition of Statistics Netherlands, which 
is based on country of birth of the person, mother 
and father. STI-endemic countries include Turkey 
and all countries in Africa, Asia, Eastern Europe and 
Latin-America.5 Categories include persons with a 
first-generation migratory background (person born 
in an STI-endemic country), and second-generation 
Table 1 Overview source of data collection and level of analysis
SOAP
Statistics 
Netherlands
Institute for 
Social Research Categories
Triage criteria
  Age chlamydia x x <20, 20–24, 25–29, 30–34, ≥35
  Age gonorrhoea <20, 20–24, 25–39, ≥40
  Notified for CT/Ng x Yes, other/unknown STI, unknown
  STI-related symptoms x No, yes
  CSW x No or unknown, yes
  Originating from an STI-endemic country x x No, first generation, second 
generation, unknown
  Partner in risk group x No, yes, unknown
  Chlamydia, gonorrhoea or syphilis in past year x No, yes
Other client characteristics
  Gender x x Men, women
  Level of education* x Low or intermediate, high, 
unknown
  Number of partners in past 6 months x 0–1, 2–3, 4–9, ≥10, unknown
  Condom use in last sexual contact x No, yes, unknown
  Ct/Ng infection x No, yes
  HIV/HBV/syphilis infection x No, yes
  Repeated consultation x No, yes
  SES on neighbourhood level (four-digit zip 
code)†
x Low, medium, high, unknown
  Degree of urbanisation‡ (four-digit zip code) x Very high, high or intermediate, 
low or very low, unknown
  STI consultation in region of living (four-digit 
zip code)
x No, yes, unknown
Regional characteristics
  Percentage men x <median, ≥median
  Percentage 15–45 years x <median, ≥median
  Percentage non-Western migrants x <median, ≥median
  Percentage with high degree of urbanisation x <median, ≥median
  Percentage with low SES x x <median , ≥median
Light grey: individual level; medium grey: neighbourhood level; dark grey, regional level.
* Low/intermediate level of education: everyone who did not have education at all or who enrolled in or completed elementary 
school, preparatory secondary vocational education or lower general secondary education; high level of education: everyone 
enrolled in or who completed the school of higher general secondary education, the pre university education, university of 
applied sciences or university. 
†SES was obtained from the SCP providing a continuous ‘status score’ per four-digit zip code of the entire Netherlands 
in 2014. This status score was based on level of education, employment and income of the inhabitants of the four-digit 
zip codes. The status scores were transformed into tertiles, with tertile one representing the lowest SES and tertile three 
representing the highest SES.
‡Very high degree of urbanisation: those living in neighbourhoods with >2500 addresses per km2; high or intermediate level of 
education: those living in neighbourhoods with 1000–2500 addresses per km2; low or very low degree of urbanisation: those 
living in neighbourhoods with <1000 addresses per km2.
Ct, Chlamydia trachomatis; Ng, Neisseria gonorrhoeae.
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migratory background (mother or father born in an 
STI-endemic country) and persons originating from 
a non-STI-endemic country.6
A partner from risk group was defined as having 
a partner originating from an STI-endemic country 
or in women as having a partner with MSM contacts. 
Missing data were incorporated in a separate category.
Other individual level client characteristics
The following other client characteristics were also 
included in the analyses: gender, level of education, 
number of sex partners in past 6 months, condom use in 
last sexual contact, infections diagnosed in the current 
consultation (Ng infection (for Ct analyses), Ct infec-
tion (for Ng analyses), infection with HIV/hepatitis B/
Table 2 Descriptive analyses of the study population
Male % Female % Total %
Age group (years) 
  <20 2175 6 8054 12 10 229 10
  20–24 17 748 50 37 339 57 55 087 54
  25–29 8245 23 11 276 17 19 521 19
  30–34 3231 9 3639 6 6870 7
  >34 4320 12 5683 9 10 003 10
Total 35 719 100 65 991 100 101 710 100
Notified STI 9501 27 10 749 16 20 250 20
  Notified chlamydia 7147 20 7924 12 15 071 15
  Notified gonorrhoea 630 2 824 1 1454 1
Not notified 26 075 73 54 962 83 81 037 80
Missing 143 0 280 0 423 0
STI-related symptoms 
  Yes 12 972 36 23 052 35 36 024 35
  No 22 747 64 42 939 65 65 686 65
Originating from an STI-endemic country
  No 24 337 68 50 799 77 75 136 74
  Yes first generation 4630 13 6788 10 11 418 11
  Yes second generation 6695 19 8307 13 15 002 15
  Missing 57 0 97 0 154 0
Partner in risk group 8888 25 16 592 25 25 480 25
Commercial sex worker 198 1 5829 9 6027 6
Chlamydia, gonorrhoea or syphilis in past year 3550 10 7960 12 11 510 11
Level of education 
  Low/intermediate 12 583 35 20 885 32 33 468 33
  High 21 175 59 40 504 61 61 679 61
  Unkwown 1961 5 4602 7 6563 6
SES on neighbourhood level 
  Low 16 252 45 26 862 41 43 114 42
  Medium 7282 20 14 223 22 21 505 21
  High 10 344 29 19 968 30 30 312 30
  Unknown 1841 5 4938 7 6779 7
Degree of urbanisation 
  Very high 18 400 52 33 781 51 52 181 51
  High or intermediate 11 335 32 19 606 30 30 941 30
  Low or very low 4211 12 7780 12 11 991 12
  Unknown 1773 5 4824 7 6597 6
SES, socioeconomic status; STI, sexually transmitted infection. 
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syphilis), repeated consultation at the same STI clinic 
during 2015, living in the region of the STI clinic 
consulted, neighbourhood SES and degree of urbanisa-
tion. The continuous variable number of sex partners was 
categorised in the groups 0–1, 2–3, 4–9, and ≥10 based 
on the relation between number of sex partners and the 
outcomes on a log odds scale. CSW who had an unknown 
number of partners were allocated to the group ≥10. A 
consultation was assigned ‘repeated’ when the person 
had a previous STI clinic consultation in 2015.
Client characteristics on neighbourhood level
Degree of urbanisation of the clients' residence address 
was obtained from CBS per four-digit zip code and cate-
gorised in three groups (1000–2500 addresses per km2 
and less or more than this range). Neighbourhood SES 
was obtained from SCP providing a continuous ‘status 
score’ per four-digit zip code in 2014, based on level of 
education, employment and income of inhabitants.7 The 
status scores were transformed into tertiles, with tertile 
one representing the lowest SES. Missing data were incor-
porated in a separate category.
Regional characteristics of STI clinic regions
Regional characteristics included the percentage of men, 
aged 15–44 years (the age group to whom the majority 
of heterosexual STI clinic visitors belong), persons orig-
inating from an STI-endemic country (first and second 
generation), persons with a high degree of urbanisation 
and persons with a low SES within each of the 24 STI 
clinic regions. The median of these 24 percentages was 
used to construct dichotomised variables (percentage in 
region <median, percentage in region ≥median).
Outcome variables
Outcome variables were binary (positive/negative) 
for either Ct or Ng infection as indicated by a positive 
Nucleic Acid Amplification Test  (NAAT) test at one or 
more anatomic locations. All analyses were performed at 
the level of visit for Ct and Ng separately.
statistical analyses
Main analyses
For each region, the Ct and Ng positivity was calculated 
by dividing the number of positives by the number of 
tests performed. The corresponding 95% CI was calcu-
lated with the following formula:  
^
p± z
√
^
p
(
1−p)
n  , where 
p=proportion with positive test, z=1.96, z-value for a 95% 
CI, n=number of tests performed. 95% CI were depicted 
with forest plots.
Two-level logistic regression at client level was used 
to analyse explanatory factors of regional differences 
in positivity, with consultations (level 1) nested within 
regions (level 2). First, a random intercept model (model 
0) without any explanatory variables was conducted to 
obtain baseline regional variance (V).
Besides model 0, three extended models were 
conducted with random intercepts and fixed slopes: 
model 1 included triage criteria, model 2 triage criteria 
and other individual level characteristics and model 3 
triage criteria, other individual level characteristics and 
Figure 2 Chlamydia trachomatis (Ct) positivity rate by sexually transmitted infection clinic region in the Netherlands, 2015. 
Black dot Ct positivity rate, line depicts lower and upper limit of 95% CI. Total Ct positivity rate is depicted as vertical line, and 
95% CI lines on the left and right.
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regional characteristics. For every model, the association 
between characteristics and outcomes were computed 
as adjusted ORs with 95% CI. Furthermore, the regional 
variance was noted. The proportional change in variance 
(PCV) was calculated to assess the extent to which the 
characteristics in the model explained regional variance.8
 PCVi =
V0−Vi
V0  , where V0 is the regional variance of 
model 0, Vi is regional variance of model i and i=2, 3.
To investigate which characteristics contributed most 
to regional variance, the percentage of contribution was 
computed for each variable separately.
 
% contribution =
V4−V3,(.)
V3,
(−k) , where V3,(−k) is the regional 
variance of model 3 without characteristic k, V3,(.) to the 
variance of model 3 with all characteristics.
Cleaning and merging of datasets and calculation 
of positivity rates were performed with SPSS V.24.0. 
Two-level logistic regression analyses were performed 
with SAS V.9.4. Forest plots were produced with Microsoft 
Excel 2010.
Additional analyses
To examine whether the associations between client 
characteristics and the outcomes differ between regions, 
model 3 was extended with random slopes for all client 
characteristics. With a backward selection procedure, 
only statistically significant (p<0.05) random slopes were 
included in the model. Subsequently, the PCV was calcu-
lated to investigate into what extent random slopes addi-
tionally explained regional variance. Furthermore, all 
analyses were repeated after missing values were imputed 
using multiple imputation (data not shown).
Patient and public involvement
Patients and or public were not involved in this retrospec-
tive study based on STI surveillance data.
results
The characteristics of the study population are shown in 
table 2.
Ct positivity
Ct positivity was 14.9% (95% CI 14.7% to 15.1%) and 
ranged from 12.6% (95% CI 11.6% to 13.6%) to 20.0% 
(95% CI 18.1% to 21.9%) regionally (figure 2). After 
including triage criteria, 11.7% of regional variance 
was explained (table 3). In this model, almost all triage 
criteria were statistically significantly associated with Ct, 
except for CSW and partner in risk group. After including 
other client characteristics, 32.2% of regional variance 
was explained. The triage criteria CSW and partner in 
risk group also became independently associated with 
Ct: CSW and those with a partner in risk group had lower 
Ct positivity. Other patient characteristics associated with 
Ct were level of education, number of partners in past 
6 months, condom use in last sexual contact, Ng co-in-
fection, repeated consultation, neighbourhood SES and 
degree of urbanisation. After including regional charac-
teristics, 59.3% of regional variance was explained. The 
only regional characteristic independently associated 
with Ct was degree of urbanisation: those living in highly 
urbanised regions had lower Ct positivity when visiting 
the STI clinic.
Table 4 Contribution of triage criteria, other client 
characteristics and regional characteristics to the regional 
variation in Ct and Ng positivity in the Netherlands, 2015, 
obtained from two-level logistic regression
% contribution of 
variable to variance*
Ct Ng
Triage criteria
  Age −38.2 −4.3
  Notified for chlamydia/gonorrhoea −15.0 +3.1
  STI-related symptoms +44.8 +30.7
  CSW +1.4 +4.2
  STI-endemic migrant +2.6 −17.2
  Partner in risk group +8.2 −11.3
  Chlamydia, gonorrhoea or syphilis 
in past year
+0.8 −3.0
Other client characteristics
  Gender −0.4 −2.0
  Level of education −15.4 −16.1
  Number of partners in past 
6 months
+15.0 +2.6
  Condom use in last sexual contact +2.2 −1.0
  Gonorrhoea/chlamydia infection −5.0 −0.1
  HIV/HBV/syphilis infection +1.1 −0.1
  Repeated consultation +18.0 +2.1
  SES on neighbourhood level −2.9 −9.4
  Degree of urbanisation +1.4 1.1
  STI consultation in region of living −1.1 −1.4
Regional characteristics
  Percentage men 0.0 −0.2
  Percentage between 15 and 
45 years
−1.1 +0.2
  Percentage non-Western migrants −5.8 −0.5
  Percentage with high degree of 
urbanisation
−24.0 −1.5
  Percentage with low SES +1.2 −18.6
*Percentage contribution of variable to regional variance. Separate 
variables are deleted from full model and variance is compared 
with variance in full model. Percentage contribution=−((variance 
full model without one variable−variance full model)/variance full 
model without one variable)×100%. This is a different measure 
than the PCV; therefore, these percentages do not add up to the 
total PCV of the full model.
Ct, Chlamydia trachomatis; CSW, commercial sex worker; Ng, 
Neisseria gonorrhoeae; PCV, proportional change in variance; SES, 
socioeconomic status; STI, sexually transmitted infection. 
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The variables age, being notified for Ct, level of 
education and regional degree of urbanisation contrib-
uted most to regional variance, respectively −38.2%, 
−15.0%, −15.4% and −24.0% (table 4). On the other 
hand, STI-related symptoms, number of partners in past 
6 months and repeated consultation increased regional 
variance after including them in the model, respectively 
+44.8%, +15.0% and +18.0%.
There were significant random slopes for age, notified, 
STI-related symptoms, partner in risk group, gender and 
repeated consultation. After adding these random slopes 
to model 3, the PCV increased to 100% (table 3).
ng positivity
Ng positivity was 1.7% (95% CI 1.6 % to 1.8%) and 
ranged from 0.8% (95% CI 0.5% to 1.1%) to 3.8% (95% 
CI 3.4% to 4.2%) regionally (figure 3). After including 
triage criteria, 38.7% of regional variance was explained. 
All triage criteria were statistically significantly associated 
with Ng (table 5). After adding other client characteris-
tics, 61.2% of regional variance was explained. Level of 
education, number of partners in past 6 months, Ct infec-
tion, repeated consultation, neighbourhood SES and 
living in region of STI clinic consultation were associated 
with Ng. After adding regional characteristics, 69.1% of 
regional variance was explained. One regional charac-
teristic independently associated with Ng was SES: those 
living in ‘low SES regions’ (defined as SES <median) had 
a borderline statistically significant higher Ng positivity 
when visiting the STI clinic.
The variables STI-endemic migrant, partner in risk 
group, level of education and SES on neighbourhood 
and regional level contributed most to regional vari-
ance, respectively −17.2%, −11.3%, −16.1%, −9.4% and 
−18.6% (table 4). On the other hand, STI-related symp-
toms increased regional variance after including it in the 
model (+30.7%).
There was a significant random slope for age. After 
adding this random slope to model 3, the PCV increased 
from 69.1% to 87.2%, with no statistically significant 
regional variance left (table 5).
DIsCussIOn
Main findings
Our study showed moderate statistically significant 
regional variance in Ct and Ng positivity among Dutch 
heterosexual STI clinic visitors. For Ct, about one-third of 
regional variance was explained by differences in client 
characteristics (mainly age, being notified for Ct and 
level of education), and 69% when adding regional char-
acteristics (mainly low degree of urbanisation). For Ng, 
about two-thirds of regional variance was explained by 
Figure 3 Neisseria gonorrhoeae (Ng) positivity by sexually transmitted infection clinic region in the Netherlands, 2015. Black 
dot Ng positivity rate, line depicts lower and upper limit of 95% CI. Total Ng positivity rate is depicted as vertical line, and 
95% CI lines on the left and right.
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differences in client characteristics (mainly STI-endemic 
migrant, partner from risk group, level of education and 
neighbourhood SES), and 59% when adding regional 
characteristics (mainly low SES).
regional variance explained by client level characteristics
In order to contribute to regional variance, a client 
characteristic has to fulfil the following conditions: 1) 
the characteristic has to be related to the outcome, 2) 
the proportion of the characteristic has to vary between 
regions and 3) the prevalence of the characteristic has to 
be sufficiently high. The client characteristics reducing 
variance most are strongly associated with Ct and Ng 
positivity, as reported previously.9–16 Furthermore, the 
proportion of visitors with these characteristics is higher 
in regions with higher positivity. Consequently, correcting 
for these variables decreased regional variance. Some 
client characteristics however increased regional variance 
when included in the model, mainly STI-related symp-
toms. This indicates that the proportion of visitors with 
STI-related symptoms in regions with higher positivity is 
lower. The reasons behind different proportions of client 
characteristics between regions might be related to STI 
clinic location by familiarity with and accessibility of STI 
clinics, balance between availability of consultations and 
requests and subsequent stringent triage application, and 
differences in demography of STI clinics adherence area 
like urbanisation and ethnicity.
The characteristics contributing most to regional vari-
ance differed between Ct and Ng, mainly because of 
varying associations between these characteristics and 
the two outcomes. For example, STI-endemic migrant, 
partner in risk group and neighbourhood SES were more 
strongly related to Ng positivity than to Ct positivity. 
Furthermore, although being notified for Ng was strongly 
associated with Ng positivity, the prevalence of Ng notifi-
cations was too low to influence regional variance.
Low/intermediate level of education was independently 
associated with Ct and/or Ng positivity and contributed 
strongly to regional variance, which confirms previous 
studies.15 17 We advise to include education as a triage 
criterion into the STI clinic access policy, as persons 
with low/intermediate education are under-represented 
at STI clinics (33%) compared with 70% in the general 
Dutch population.4
regional variance explained by regional characteristics
Regional SES explained part of regional variance in Ng 
positivity. Living in a low SES region increased Ng posi-
tivity independent of neighbourhood SES and level of 
education. This suggests that there is clustering of Ng 
among heterosexuals within low SES neighbourhoods 
and regions. Previous studies also found clustering of 
Ng within low SES regions and among migrant popula-
tions.9–11 16 18 Neighbourhood and regional SES had no 
influence on regional variance in Ct positivity, as is also 
described previously.19 However, regional degree of urban-
isation was an important contributor to regional variance 
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in Ct. Living in urbanised regions decreased Ct positivity 
at STI clinics. This is apparently in contrast to previous 
Dutch studies in which a high degree of urbanisation was 
related to higher Ct prevalence.17 20 A large proportion of 
visitors is from urbanised areas where most STI clinics are 
located. Visitors from low urbanised areas visit STI clinics 
less frequently but those that do visit the STI clinic have 
a higher Ct positivity rate possibly due to effective self-se-
lection. Additional analyses showed that high urbanised 
regions had lower Ct positivity rates among those notified 
for Ct and among those with STI-related symptoms than 
low urbanised regions (not shown). Possibly, inhabitants 
of urbanised regions are more familiar with and have 
easier access to STI clinics.
unexplained regional variance
Part of regional variance remained unexplained. After 
including significant random slopes in model 3, all 
regional variance was explained. The differential associa-
tion between these characteristics and infection between 
regions explained all remaining regional variance. This 
implies that Ct/Ng risk of an STI clinic visitor differs 
between regions, even when client characteristics are 
similar. This may be caused by differences in the self-selec-
tion of persons visiting the STI clinic and in prioritising 
practices at STI clinics between regions, but it may also 
reflect real regional differences. Previous studies reported 
strong evidence for spatial Ng clustering in the UK and 
the USA, independent of sociodemographic regional 
factors.10 18 21–24 Also regional Ct clusters have been 
reported, although they were less strong and more diffuse 
compared with Ng clusters.25 Studies incorporating prev-
alence data are needed to assess whether regional clus-
tering of Ct and Ng is present in the Netherlands.
strengths and limitations
Analysing a nationwide database with a large set of demo-
graphic and behavioural characteristics enabled us to 
study a range of explanatory variables. By using a multi-
level approach, it was possible to quantify the contribu-
tion of characteristics of STI clinic visitors to the regional 
variance in positivity. To the best of our knowledge, this 
has not been done before. There are also some limita-
tions to address. First, in 15% of consultations data 
were incomplete for some variables of interest, varying 
between 0.1% and 6.7%. Missing data were incorporated 
as a separate group, which could have distorted results. 
However, missing data were imputed using multiple 
imputation, and results remained robust (not shown).26 
Second our study is limited to STI clinic visitors, and did 
not account for STI related consultations at GP practices. 
STI visitors are at high risk, partially due to self-selection 
and due to triage, and therefore do not reflect the Dutch 
population.27 28 As our aim was to explain regional vari-
ance within the STI clinic data and not to investigate the 
real positivity, this is in fact not limiting the results of our 
study. Third, although a large set of characteristics was 
available, residual confounding remains possible.
COnClusIOn AnD reCOMMenDAtIOns
We found statistically significant regional variance in Ct 
and Ng positivity among Dutch heterosexual STI clinic 
visitors. Regional variance was explained by differences 
in client characteristics, indicating that triage and self-se-
lection influence positivity rates in the surveillance data. 
Client characteristics explained a larger part of regional 
variance in Ng than in Ct suggesting that Ng is more 
concentrated in high-risk persons.29 Furthermore, our 
results indicate Ng clustering among heterosexuals within 
low SES neighbourhoods and regions; targeted interven-
tions in low SES regions may therefore be valuable for 
Ng control. STI clinics might strengthen their efforts to 
include young lower educated heterosexuals to improve 
Ct control, and also increase their efforts in reaching 
more low educated persons from low SES and/or migrant 
origin in case of Ng control. Although prevalence studies 
are known to have methodological and practical chal-
lenges and are scarce, they are needed to assess whether 
real regional differences appear. Furthermore, each STI 
clinic should investigate the characteristics of their clients 
at highest risk to develop targeted prioritising policy 
and ideally combine this information with data from GP 
patients to get a complete regional perspective.
Author affiliations
1Centre for Infectious Disease Control, National Institute for Public Health and the 
Environment, Rotterdam, The Netherlands
2Department of Infectious Disease Control, Municipal Public Health Service 
Rotterdam-Rijnmond, Rotterdam, The Netherlands
3Department of Public Health, Erasmus MC—University Medical Center Rotterdam, 
Rotterdam, The Netherlands
4Department of Sexual Health, Infectious Diseases and Environmental Health, Public 
Health Service South Limburg, Geleen, The Netherlands
5Department of Medical Microbiology, Maastricht University Medical Centre, Care 
and Public Health Research Institute, Maastricht, The Netherlands
Acknowledgements The authors would like to thank the co-workers of the 24 
Dutch STI clinics for the thorough data entry of all consultations. The authors 
would also like to thank Dr Jan van de Kassteele and Dr David van Klaveren for 
their statistical advice and to Dr Maarten Schipper for performing the multiple 
imputation. 
Contributors HG initiated the study, helped interpreting the data and drafted 
and revised the manuscript. LvO initiated the study, analysed and interpreted the 
data and drafted the manuscript. BvB and CJPAH helped interpreting the data and 
revised the manuscript draft. All authors read and approved the final manuscript. 
Funding The authors have not declared a specific grant for this research from any 
funding agency in the public, commercial or not-for-profit sectors. 
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Results of analyses on the imputed datasets are available 
on request from the corresponding author after permission of the registration 
committee for the Dutch STI clinic database. The Corresponding Author has the 
right to grant on behalf of all authors and does grant on behalf of all authors, an 
exclusive licence (or non-exclusive for government employees) on a worldwide 
basis to the BMJ Publishing Group Ltd (BMJPGL) to permit this article (if accepted) 
to be published in BMJ open and any other BMJPGL products and sublicences such 
use and exploit all subsidiary rights, as set out in our licence http:// group. bmj. com/ 
products/ journals/ instructions- for- author. 
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
 o
n
 28 February 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022793 on 21 January 2019. Downloaded from 
15Götz HM, et al. BMJ Open 2019;9:e022793. doi:10.1136/bmjopen-2018-022793
Open access
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. Spiteri G. Sexually transmitted infections in Europe 2013. Stockholm: 
ECDC, 2015.
 2. Visser M, van Aar F, van Oeffelen A, et al. Sexually transmitted 
infections in the Netherlands in 2016. Bilthoven: RIVM, 2017.
 3. Draaiboek Consult seksuele gezondheid - Deeldraaiboek 6: 
Testbeleid. 2015. http://www. rivm. nl/ dsresource? objectid= 94096dc6- 
ae14- 49fb- ad8a- 06f10883bc14& type= pdf& disposition= inline: soa-
LOI
 4. Visser M, van Aar F, van Oeffelen AAM, et al. Sexually transmitted 
infections including HIV, in the Netherlands in 2016. Bilthoven, The 
Netherlands: RIVM, 2017.
 5. RIVM. Lijst soa/hiv-endemische landen. Bilthoven: RIVM, 2012.
 6. Stronks K, Kulu-Glasgow I, Agyemang C. The utility of 'country of 
birth' for the classification of ethnic groups in health research: the 
Dutch experience. Ethn Health 2009;14:255–69.
 7. Knol FA. Van hoog naar laag; van laag naar hoog: Den Haag Sociaal 
Cultureel Planbureau, 2009.
 8. Merlo J, Yang M, Chaix B, et al. A brief conceptual tutorial on 
multilevel analysis in social epidemiology: investigating contextual 
phenomena in different groups of people. J Epidemiol Community 
Health 2005;59:729–36.
 9. Lacey CJ, Merrick DW, Bensley DC, et al. Analysis of the 
sociodemography of gonorrhoea in Leeds, 1989-93. BMJ 
1997;314:1715–8.
 10. Sullivan AB, Gesink DC, Brown P, et al. Are neighborhood 
sociocultural factors influencing the spatial pattern of gonorrhea in 
North Carolina? Ann Epidemiol 2011;21:245–52.
 11. Du P, McNutt LA, O'Campo P, et al. Changes in community 
socioeconomic status and racial distribution associated with 
gonorrhea rates: an analysis at the community level. Sex Transm Dis 
2009;36:430–8.
 12. Hickman M, Judd A, Maguire H, et al. Incidence of gonorrhoea 
diagnosed in GUM clinics in South Thames (west) region. Sex Transm 
Infect 1999;75:306–11.
 13. McDonagh P, Ryder N, McNulty AM, et al. Neisseria gonorrhoeae 
infection in urban Sydney women: prevalence and predictors. Sex 
Health 2009;6:241–4.
 14. James AB, Geisler WM. Predictors of high chlamydia and gonorrhea 
positivity rates among men in the southern United States. J Natl Med 
Assoc 2012;104(1-2):20–7.
 15. Corsenac P, Noël M, Rouchon B, et al. Prevalence and 
sociodemographic risk factors of chlamydia, gonorrhoea and 
syphilis: a national multicentre STI survey in New Caledonia, 2012. 
BMJ Open 2015;5:e007691.
 16. Rice RJ, Roberts PL, Handsfield HH, et al. Sociodemographic 
distribution of gonorrhea incidence: implications for prevention and 
behavioral research. Am J Public Health 1991;81:1252–8.
 17. van Bergen J, Götz HM, Richardus JH, et al. Prevalence of 
urogenital Chlamydia trachomatis increases significantly with level 
of urbanisation and suggests targeted screening approaches: results 
from the first national population based study in the Netherlands. Sex 
Transm Infect 2005;81:17–23.
 18. Le Polain De Waroux O, Harris RJ, Hughes G, et al. The 
epidemiology of gonorrhoea in London: a Bayesian spatial modelling 
approach. Epidemiol Infect 2014;142:211–20.
 19. van Klaveren D, Götz HM, Op de Coul EL, et al. Prediction of 
Chlamydia trachomatis infection to facilitate selective screening 
on population and individual level: a cross-sectional study of 
a population-based screening programme. Sex Transm Infect 
2016;92:433–40.
 20. Götz HM, van Bergen JE, Veldhuijzen IK, et al. A prediction rule for 
selective screening of Chlamydia trachomatis infection. Sex Transm 
Infect 2005;81:24–30.
 21. Jennings JM, Curriero FC, Celentano D, et al. Geographic 
identification of high gonorrhea transmission areas in Baltimore, 
Maryland. Am J Epidemiol 2005;161:73–80.
 22. Law DC, Serre ML, Christakos G, et al. Spatial analysis and mapping 
of sexually transmitted diseases to optimise intervention and 
prevention strategies. Sex Transm Infect 2004;80:294–9.
 23. Risley CL, Ward H, Choudhury B, et al. Geographical and 
demographic clustering of gonorrhoea in London. Sex Transm Infect 
2007;83:481–7.
 24. Shaw SY, Nowicki DL, Schillberg E, et al. Epidemiology of incident 
chlamydia and gonorrhoea infections and population attributable 
fractions associated with living in the inner-core of Winnipeg, 
Canada. Int J STD AIDS 2017;28:550–7.
 25. Schleihauf E, Watkins RE, Plant AJ. Heterogeneity in the spatial 
distribution of bacterial sexually transmitted infections. Sex Transm 
Infect 2009;85:45–9.
 26. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing 
data in epidemiological and clinical research: potential and pitfalls. 
BMJ 2009;338:b2393.
 27. de Graaf H, Kruijer H, van Acker J, et al. Seks onder je 25e 2: 
Seksuele gezondheid van jongeren in Nederland anno 2012. Delft: 
Eburon, 2012.
 28. Creighton S, Edwards S, Welch J, et al. News from the frontline: 
sexually transmitted infections in teenagers attending a genitourinary 
clinic in south east London. Sex Transm Infect 2002;78:349–51.
 29. Jolly AM, Wylie JL. Gonorrhoea and chlamydia core groups and 
sexual networks in Manitoba. Sex Transm Infect 2002;78:i145–51.
 o
n
 28 February 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022793 on 21 January 2019. Downloaded from 
